Position in JNJ
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$112,254
+$79,988 QoQ
Shares Held
442
+234.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#4,566
of 4,676 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DecisionPoint Financial, LLC holds $178,833 across 10 Drug Manufacturers - General names. JNJ ranks #1 (62.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
442 | $112,254 | |
| 2 | LLY |
ELI LILLY & Co
|
28 | $33,584 | |
| 3 | MRK |
Merck & Co., Inc.
|
143 | $18,375 | |
| 4 | NVS |
Novartis AG
|
25 | $3,918 | |
| 5 | ABBV |
AbbVie Inc.
|
13 | $3,271 | |
| 6 | AMGN |
Amgen Inc
|
6 | $2,172 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
13 | $1,642 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
24 | $1,382 |
All Filings in JNJ
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $112,254 | 442 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $32,266 | 132 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $30,421 | 147 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $13,350 | 72 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $50,407 | 330 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $51,410 | 310 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $51,340 | 355 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $57,531 | 355 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $45,309 | 310 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $49,038 | 310 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $48,589 | 310 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $48,282 | 310 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $51,311 | 310 | Shares | Sole | 2023-09-26 | |
| 2023-03-31 | $48,050 | 310 | Shares | Sole | 2023-09-26 | |
| 2022-12-31 | $54,761 | 310 | Shares | Sole | 2023-09-26 | |
| No filing history on record for this holder in this stock. | ||||||